The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study

This case series study investigated the effectiveness of oral dutasteride, minoxidil, and finasteride in treating endocrine therapy-induced alopecia (EIA) in 8 breast cancer survivors. Over an average of 15 months, patients experienced decreased hair shedding and varying degrees of regrowth, with the most notable improvement in a patient using finasteride and topical minoxidil. The treatments were generally well-tolerated, though facial hirsutism was a common side effect of oral minoxidil. The study indicates potential benefits of these treatments for EIA, but emphasizes the need for further research to fully understand their safety and efficacy in this hormonally sensitive group.